Ταυτότητα

Dalilesen Impurity 3

Δεν αναφέρεται · C18H26ClN3O3

01Ταυτότητα

Lazychem IDLC-36206
CAS RNΔεν αναφέρεται
PubChem CID118142609
Molecular formulaC18H26ClN3O3
Molecular weight367.9 g/mol
IUPAC nametert-butyl (2S)-2-[(2-amino-4-chloro-3-methylphenyl)carbamoyl]-2-methylpyrrolidine-1-carboxylate
InChIKeyCORFQPFEGSYSRN-SFHVURJKSA-N

02Δομή και στερεοχημεία

Two-dimensional chemical structure of Dalilesen Impurity 3
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count2
Secondary amines0
Tertiary amines0
SMILESCC1=C(C=CC(=C1N)NC(=O)[C@@]2(CCCN2C(=O)OC(C)(C)C)C)Cl
InChIΔεν αναφέρεται

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Κατάσταση στην Ινδία

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Ονόματα και σχέσεις

API και μητρικό φάρμακο

Δεν αναφέρεται

Ονόματα και σχέσεις

    06Πηγές